Markets
Rockwell Med (RMTI)
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Rockwell Med, with a price target of $5.50. The company’s shares closed last Friday at $1.06, close to its 52-week low of $0.83.
According to TipRanks.com, Selvaraju is a 4-star analyst with an average return of 13.2% and a 52.3% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as NeuroBo Pharmaceuticals, Bausch Health Companies, and Oramed Pharmaceuticals.
Currently, the analyst consensus on Rockwell Med is a Moderate Buy with an average price target of $5.50.
Biogen (BIIB)
In a report released today, Salim Syed from Mizuho Securities maintained a Hold rating on Biogen, with a price target of $244.00. The company’s shares closed last Friday at $262.63.